-
Institutional Research! The pharmaceutical stock has attracted the attention of more than 350 institutions
Time of Update: 2022-11-11
According to statistics from DataBao, in the past five trading days (October 31 to November 4), more than 360 listed companies in Shanghai and Shenzhen have been investigated by institutions, of which
-
The 2022 Hurun Rich List is announced, and 11 medical professionals are in the top 100!
Time of Update: 2022-11-11
【Pharmaceutical Network Industry News】On November 8, Hurun Research Institute released the "2022 Hurun Report", which showed that a total of 1,305 entrepreneurs with personal wealth of more than 5 billion yuan appeared on this year's Hurun Report, a decrease of 11% compared with last year.
-
Countdown to 5 days! Have you not booked a solid alternative fuels webinar yet?
Time of Update: 2022-11-11
【Pharmaceutical Network Conference Forum】Leng Qiu reported, visiting the exhibition is just right. What could be happier than being able to visit exhibitions, watch forums, send purchases, and hand ov
-
Do you rush for an exhibition full of benefits? 2022 Vision Expo Autumn Exhibition Registration Entrance Summary
Time of Update: 2022-11-11
2022 Sight Fair Autumn Exhibition Tel: 0571-87756933; QQ:568547636。【Pharmaceutical Network Exhibition Report】The 2022 TV Fair Autumn Exhibition will be launched on November 15, registration is nearing completion, please get on the bus as soon as possible for passengers who have not yet boarded!
-
Pharmaceutical companies actively promote consistency evaluation, and recently a number of drugs have been evaluated
Time of Update: 2022-11-11
, Ltd. announced that the branch Harbin Pharmaceutical General Factory recently received the "Drug Supplement Application Approval Notice" issued by the State Medical Products Administration on flunarizine hydrochloride capsules, and the drug passed the consistency evaluation of the quality and efficacy of generic drugs.
-
Pharmaceutical innovation needs to inject new impetus and vitality, and CRO companies have increased the construction of R&D bases during the year
Time of Update: 2022-11-11
Upstream equipment industry may embrace opportunities In the context of increasing the construction of R&D and production bases, CRO enterprises will also increase investment in related software and hardware in order to meet the requirements of pharmaceutical companies.
-
Multinational pharmaceutical companies remain confident in the Chinese market and are determined to deepen their development
Time of Update: 2022-11-11
【Pharmaceutical Network Industry News】The Chinese market has always been an important market in the global strategy of multinational pharmaceutical companies. Statistics show that in 2021, China's pha
-
Announce to the whole network: the autumn exhibition of the 2022 Vision and Environmental Protection Conference has begun!
Time of Update: 2022-11-11
【Pharma Network Exhibition Report】At 10 a. m. on November 8, the 2022 Sight and Environmental Protection Fair Autumn Exhibition hosted by Environmental Protection Online was grandly opened. The seven-
-
The acceleration of new drug launches in China is bringing more choices for clinical treatment
Time of Update: 2022-11-11
On November 7, Jinxing Pharmaceutical announced that the Center for Drug Evaluation of the State Food and Drug Administration has accepted its application for the marketing of omecamtiv mecarbil, whic
-
Facing the challenge of refined operations, pharmaceutical companies are actively exploring new models of digital health
Time of Update: 2022-11-11
At the 5th China International Import Expo, a large number of multinational pharmaceutical companies signed strategic cooperation agreements with Alibaba Health to jointly explore a patient-centered full-link digital medical and health service model to improve the health level and quality of life of patients.
-
Innovation is unstoppable! The revenue of innovative drugs of leading pharmaceutical companies will strive to increase by 10 billion yuan
Time of Update: 2022-11-11
Through continuous R&D investment, the revenue of innovative drugs of many pharmaceutical companies will strive to increase by 10 billion yuan.
Through continuous R&D investment, the revenue of innovative drugs of many pharmaceutical companies will strive to increase by 10 billion yuan.
-
Focus on "Waste-free City" and book this unique summit forum!
Time of Update: 2022-11-11
m. on November 10, follow the perspective of experts, approach the "waste-free city", and deepen the way of solid waste resource treatment!【Pharma Network Conference Forum】2022 Visual Environment Fair-Autumn Exhibition Accelerates Approaching!
-
For pharmaceutical companies that are keen on "buying, buying, buying", the failure of acquisitions has become the norm
Time of Update: 2022-11-11
Regarding the reasons for terminating the acquisition, Clarion said that due to regulatory reasons, the company and Snapdragon have not yet agreed on future development plans and countermeasures.
-
2023 China (Shanghai) International Soft Start Technology and Equipment Exhibition
Time of Update: 2022-11-05
2023 China (Shanghai) International Soft Start Technology and Equipment Exhibition China (Shanghai) International Soft Start Technology and Equipment Exhibition2023 Essential information Date: 2023.
-
The intelligent manufacturing equipment industry has set off a development boom, and the pharmaceutical machinery industry is expected to benefit
Time of Update: 2022-11-05
At that time, after the fourth phase of the project reaches full production, Chutian Technology will form a production capacity of 10 billion yuan and become a global professional medical equipment research and development and intelligent manufacturing base.
-
These new regulations came into effect in November and involve food, medicine, medical insurance, and other aspects
Time of Update: 2022-11-05
November is coming A number of new regulations closely related to life will be implemented soon Involving food, medicine, medical insurance, etc Let's find out ↓↓ Strengthen the protection of the lawful rights and interests of individual industrial and commercial households The Regulations on Promoting the Development of Individual Businesses will come into force on 1 November, stipulating: The government and its relevant departments shall not discriminate against individual industrial and commercial enterprises when formulating relevant policies and measures.
-
2023 Shanghai International Rust Inhibitor and Application Technology Exhibition
Time of Update: 2022-11-05
2023 Shanghai International Rust Inhibitor and Application Technology Exhibition hanghai International Anti rust Agent and Application Technology Exhibition Essential information Date: 2023. 04. 26-2
-
2023 China (Beijing) International Cross-media Technology and Equipment Exhibition
Time of Update: 2022-11-05
【Audience Invitation】 Broadcast, film and television broadcasting institutions/film and television program production institutions/colleges, education and training institutions/studio engineering/cable, terrestrial and satellite networks/new media/VR media/government departments and senior management/equipment wholesalers, traders, distributors/import and export companies, overseas traders/network services and content provision/R&D and manufacturing institutions/photography and image institutions/cinemas, distribution institutions and individuals/other related enterprises or individuals, research institutions/universities, financial institutions, media and other 。 【Exhibition advantages】 ◇Extensive media publicity: through professional magazines.
-
2023 Beijing International Integrated Cabling and Optical Fiber Communication Exhibition
Time of Update: 2022-11-05
2023 Beijing International Integrated Cabling and Optical Fiber Communication Exhibition Beijing International Generic Cabling and Optical Fiber Communication Exhibition2023 【Basic Information】 When:
-
Publication of a national action plan to contain microbial resistance (2022-2025)
Time of Update: 2022-11-05
All provinces, autonomous regions, municipalities directly under the Central Government, and the Xinjiang Production and Construction Corps Health Commission, Education Department (Education Commissi
